G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 102 filers reported holding G1 THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 6.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $213,000 | +5.4% | 8,854 | +15.7% | 0.03% | +7.4% |
| Q4 2019 | $202,000 | -14.0% | 7,654 | 0.0% | 0.03% | +8.0% |
| Q2 2019 | $235,000 | -39.0% | 7,654 | +4.1% | 0.02% | -10.7% |
| Q3 2018 | $385,000 | +20.3% | 7,354 | 0.0% | 0.03% | +16.7% |
| Q2 2018 | $320,000 | +17.6% | 7,354 | 0.0% | 0.02% | +14.3% |
| Q1 2018 | $272,000 | -6.8% | 7,354 | -50.0% | 0.02% | 0.0% |
| Q4 2017 | $292,000 | – | 14,709 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 1,423,794 | $34,541,000 | 9.18% |
| Burrage Capital Management LLC | 373,876 | $9,070,000 | 6.35% |
| Birchview Capital, LP | 40,000 | $970,000 | 0.59% |
| 361 CAPITAL LLC | 47,325 | $1,148,000 | 0.54% |
| Rhenman & Partners Asset Management AB | 190,000 | $4,609,000 | 0.50% |
| CHI Advisors LLC | 44,000 | $1,067,000 | 0.42% |
| Bellevue Group AG | 721,925 | $17,514,000 | 0.25% |
| Candriam S.C.A. | 870,423 | $21,117,000 | 0.22% |
| Virtus ETF Advisers LLC | 18,991 | $461,000 | 0.22% |
| HHLR ADVISORS, LTD. | 949,431 | $23,033,000 | 0.21% |